Roivant Sciences Ltd.: President & Immunovant CEO Venker Eric sold 200,000 shares

What happened Venker Eric, president & Immunovant CEO, sold 200,000 common shares in two transactions on Oct 20, 2026, for a total of $7,022,667. He sold 185,856 shares at a weighted average price of $35.09 for $6,521,687 and 14,144 shares at a weighted average price of $35.42 for $500,980.

Key details

• Transaction date: Oct 20, 2026. Filing date: Oct 22, 2026. Accession: 0001635088-26-000116.
• Prices and ranges: 185,856 shares at weighted avg $35.09 (sales ranged $34.38 to $35.38); 14,144 shares at weighted avg $35.42 (sales ranged $35.39 to $35.51).
• Shares owned after the transaction: not reported in the provided filing excerpt.
• Footnotes: the prices shown are weighted averages and the reporting person will provide a per-price breakdown on request. The filing states these sales were effected pursuant to a Rule 10b5-1 trading plan adopted on Jun 30, 2026.

Why it may matter

• These were reported as sales executed under a Rule 10b5-1 trading plan.
  A filing does not show why the insider traded or why the company acted.